[Problem analysis. Evaluation of therapeutic means and objectives].
There is an inadequacy between the increasingly effective antiarrhythmia drugs at our disposal for the treatment of ventricular arrhythmias, their increasingly accurate and standardised evaluation by different invasive and non-invasive methods, and the pertinence of their clinical usage, especially in terms of patient safety. The reason why this situation has occurred are analysed in order to review a number of beliefs which have been too easily adopted without sufficient discussion.
Coumel
P
P
Service de cardiologie, hôpital Lariboisière, Paris.
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D017147:Defibrillators, Implantable; D004569:Electroencephalography; D006352:Heart Ventricles; D006801:Humans; D011340:Problem Solving; D017180:Tachycardia, Ventricular / Q000145:classification / Q000175:diagnosis / Q000628:therapy
D000889:Anti-Arrhythmia Agents
Formulation des problèmes. Evaluation des moyens et des objectifs thérapeutiques.